Clinical experience with transcutaneous supraorbital nerve stimulation in patients with refractory migraine or with migraine and intolerance to topiramate: a prospective exploratory clinical study

BMC Neurology

Table 1 Satisfaction and compliance at the end of 3-months trial of Cefaly®

	N (%)
Satisfaction-intent to continuation
Yes	23 (65,7%)
No	12 (34,3%)
Completed 3 months trial
Yes	27 (81,8%)
No	6 (18,2%)